Pune, India -- (SBWire) -- 09/29/2017 --The Global Salivary Gland Infection Market report explores competitive expert analysis report explores the market by diagnosis (plain radiography, sialography, and others), by treatment (medication, surgery, aspiration, and others), by end user- Forecast till 2023.
Worldwide Salivary Gland Infection Market Synopsis: Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland. Increasing prevalence of various salivary gland infections, changing disease patterns, and environmental changes are major drivers for the market growth. Rising funding for R&D and clinical trials are leading to improved product development is another key factor for market growth.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/3779 .
Improved hygiene practices, growing awareness about self-care and advanced diagnosis and treatment options are important driving forces for the market. The global salivary gland infection market is growing at the CAGR of ~6.7% during the forecast period and expected to reach US$ 3622.6 million by 2023.
Study objectives of global salivary gland infection market:
To provide detailed analysis of the global salivary gland infection market structure with historical and forecast revenue for the next 6 years of the various segments and sub-segments.
To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global salivary gland infection market.
To provide analysis of the market with respect to four main geographies and their countries – the Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide detailed analysis of the market segmented by diagnosis, treatment, end user, and its sub-segments.
To provide a detailed analysis of global salivary gland infection market mainly based on Value Chain analysis, Porter's Five Forces, Price analysis, and Supply Chain analysis etc.
Segments:
Global salivary gland infection market has been segmented on the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.
On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.
Get Discount @ https://www.marketresearchfuture.com/check-discount/3779 .
Global Salivary Gland Infection Market Synopsis:
Market scenario:
Regional Analysis:
Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
Key Players for global salivary gland infection market:
Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany), and others.
Inquire more @ https://www.marketresearchfuture.com/enquiry-before-buy/3779 .
The report for Global Salivary Gland Infection Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and global regions.
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Salivary Gland Infection Market Estimated to Acquire Enormous Growth by 2023
The Global Salivary Gland Infection Market report gives detailed analysis of the global Salivary Gland Infection industry structure with historical and forecast revenue for the next six years of the various segments and sub-segments.